Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane

We are Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane CAS:76272-56-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane
CAS.NO:76272-56-5
Synonyms:
9-Azabicyclo[3.3.1]nonan-3-amine, 9-methyl-
(3-endo)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine
9-Azabicyclo[3.3.1]nonan-3-amine, 9-methyl-, (3-endo)
9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine

Molecular Formula: C9H18N2
Molecular Weight:154.25300

Physical and Chemical Properties:
Density: 0.968 g / cm3
Boiling point: 115-119ºC (18 mmHg)
Melting point: 72.1ºC
Flash point: 67.3ºC
Refractive index: 1.517

Specification:
Appearance:Colorless or yellowish transparent liquid
Purity:≥98.5%
Water:≤1.0%
Oxime:≤0.2%
Individual impurities:≤0.5%
Total impurity:≤1.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Granisetron hydrochloride CAS:107007-99-8

Related News: However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.3-[(1S)-1-(dimethylamino)ethyl]phenol CAS:139306-10-8 DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.Methyl 4-[(5-amino-1-methylindol-3-yl)methyl]-3-methoxybenzoate Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease.1,3,5,7-tetramethylcyclotetrasiloxane CAS:2370-88-9 Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease.The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.